Missing/wrong data?
Log in to edit
Polatuzumab vedotin, an anti-CD79b antibody-drug conjugate for the treatment of relapsed/refractory diffuse large B-cell lymphoma
scientific article published on 21 September 2020
Author/s
author: Vincent Camus, Hervé Tilly
Work details
Publication date
September 21, 2020
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.